Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05844384 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 6, 2023 (before its estimated March 17, 2024 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This randomized, single-masked, crossover, non-inferiority trial aims to evaluate the safety and efficacy of Nanodropper-mediated microdrops of ocular hypotensive topical treatments (experimental intervention) compared to standard drops of the same medication(s) (active comparator) in Wilford Hall Ambulatory Surgical Center (WHASC) primary open-angle glaucoma (POAG) and ocular hypertension (OHTN) patients.
Trial Details
NCT Number NCT05844384
Lead Sponsor 59th Medical Wing
Collaborators: Nanodropper, Inc.
Conditions
(from sponsor)		 Ocular Hypertension, Primary Open Angle Glaucoma
Related terms Glaucoma, Open-Angle, Ocular Hypertension
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov